Latest / Alabama's Morning News with JT / Healthy Living Expert Paul Fulford joins JT to discuss peptide safety
Transcript
- 0:00Speaker 1: Paul full for joined us now Healthy Living Expert. We've
- 0:04Speaker 1: had them on before. Paul, welcome back in, thanks for
- 0:06Speaker 1: being here, Thank you for having me. JT. You know,
- 0:08Speaker 1: the craze right now seems to be the GLP ones.
- 0:11Speaker 1: I've been on them for almost a year and a
- 0:13Speaker 1: half now I think I lost forty pounds with them.
- 0:15Speaker 1: I'm pro GLP one's been taking zep bound for a while.
- 0:19Speaker 1: But when I first started taking them, I had a
- 0:23Speaker 1: compound that you know, you'd fill it from a vial
- 0:27Speaker 1: your own yourself and then syringe it in. Now I
- 0:30Speaker 1: get it directly zet bound from Lily because they proved it,
- 0:35Speaker 1: and it's cheaper now through insurance because they've approved it
- 0:38Speaker 1: for sleep APNA. They've approved approved them obviously for you know,
- 0:43Speaker 1: type two diabetes, and my cardiologists like, yes, stay on them.
- 0:46Speaker 1: I mean, there's so many benefits from these GLP ones.
- 0:49Speaker 1: The compound I had, though one of them was peptides
- 0:52Speaker 1: were added to it. The other one had fidamin B twelve,
- 0:55Speaker 1: so and I've taken peptides before. As far as you know,
- 0:59Speaker 1: over night drops some drops in your mouth and it
- 1:02Speaker 1: helps with you know, losing weight over night. Proteins. So
- 1:06Speaker 1: talk to me about peptides, what they're all about, and
- 1:08Speaker 1: what the dangers are is where as far as where
- 1:10Speaker 1: you buy these peptides, because they seem to be available
- 1:14Speaker 1: just as anything else in gas stations now you can
- 1:18Speaker 1: pick up somewhat garbage products. But so let's first of
- 1:22Speaker 1: all talk peptides. You've been using them for a while too.
- 1:25Speaker 2: Yes, I've been using them, I guess before they were
- 1:28Speaker 2: considered proscience, and it was because the mechanism of action.
- 1:32Speaker 2: I mean, what peptides are just short chain aminos that
- 1:36Speaker 2: basically send instructions and signals, right, And I think where
- 1:40Speaker 2: it goes sideways every time is when these these things
- 1:44Speaker 2: come up that they're dangerous. You know, Peptides are medicine,
- 1:47Speaker 2: you mentioned, you know the GLP ones. Insulin is a peptide,
- 1:50Speaker 2: you know, and you can have peptides and there's something
- 1:53Speaker 2: like one hundred over one hundred FAA proved drugs that
- 1:57Speaker 2: have peptides in them already on the market, and there's
- 1:59Speaker 2: about one hundred and fifty more in clinical trials. So
- 2:02Speaker 2: when people say it's dangerous, my answers really know the
- 2:05Speaker 2: molecule isn't the problem. The great market is the problem.
- 2:08Speaker 2: The lack of oversights the problem. And I think those
- 2:10Speaker 2: are two different conversations.
- 2:13Speaker 1: So you're pro peptides and you know, if you get
- 2:15Speaker 1: them from the right source, they're great. Should these things
- 2:18Speaker 1: be when you talk about regulation prescription to that point?
- 2:24Speaker 2: You know recently there is a reclassification, right they went
- 2:30Speaker 2: on the category two list because they were said that
- 2:34Speaker 2: they were dangerous and there was no reason to put
- 2:36Speaker 2: them on the category two list. So the problem with
- 2:39Speaker 2: getting them actually prescribed, the ones that are on that list,
- 2:42Speaker 2: like most popularly BPC one fifty seven for repair and such,
- 2:48Speaker 2: is that it puts a clinician at risk if they
- 2:51Speaker 2: prescribed them because they're considered dangerous. Right, So recently in April,
- 2:58Speaker 2: you know, RFK had a rec classification of these and
- 3:02Speaker 2: we're in we're going to be having a real vote
- 3:05Speaker 2: in July to move all of this forward so that
- 3:07Speaker 2: those twelve that were on that category two list get removed.
- 3:11Speaker 2: So it's that they're available. And then the biggest problem
- 3:16Speaker 2: that the drug companies have with it, like you mentioned,
- 3:19Speaker 2: you know Zepic manjar O Wigovi, they can't patent the
- 3:25Speaker 2: actual peptide. They can patent the brand name, they can
- 3:28Speaker 2: patent the delivery mechanism, and they can patent the dosage.
- 3:31Speaker 2: So why it's hard for drug companies to want to
- 3:35Speaker 2: invest in peptides from a clinical standpoint and trial standpoint
- 3:40Speaker 2: is that all you have to do when we've had
- 3:42Speaker 2: a problem getting BPC one fifty seven, you get what's
- 3:46Speaker 2: called pentadeca origin eight, which is just basically the BPC
- 3:49Speaker 2: compound with rginat added to it, so then it changes
- 3:52Speaker 2: what it is and then you can use it. Right,
- 3:54Speaker 2: That's been the kind of the workaround for the compounding pharmacies.
- 3:58Speaker 1: All right, Well, listen, there's a lot of moving life
- 4:00Speaker 1: and all of this and apparently a lot of different
- 4:03Speaker 1: peptide strains if you will, varieties if you will, out there.
- 4:09Speaker 1: So there are kids and people that are buying these
- 4:12Speaker 1: things across Instagram, TikTok YouTube that are unapproved and harmful
- 4:17Speaker 1: peptide products. So where is one to get the best
- 4:20Speaker 1: peptides from? Talk to your doctor, Do you order from
- 4:25Speaker 1: you know, medhelp dot com or where do you suggest
- 4:28Speaker 1: people get peptides and start the conversation about the benefits.
- 4:33Speaker 2: Well, I would say that first, yes, you need to
- 4:35Speaker 2: consult the clinician. Right, you don't just need to take
- 4:38Speaker 2: some influencer's word on TikTok. You know, that's the part
- 4:41Speaker 2: that scares people because what's actually being sold over Instagram
- 4:44Speaker 2: in most cases it literally comes in a bile that
- 4:48Speaker 2: says for research purposes only, not for human use. You know,
- 4:52Speaker 2: when you're trying to get an actual peptide one, you
- 4:55Speaker 2: need to get bloodline, you need to get blood work,
- 4:57Speaker 2: a baseline for your blood work to understand what are
- 4:59Speaker 2: the the actual benefits of it. And then there's two
- 5:02Speaker 2: main categories for peptides. There's ones that you know bind
- 5:06Speaker 2: our receptor pro receptor, and then there are some that
- 5:10Speaker 2: don't necessarily need a receptor for using them. So you
- 5:14Speaker 2: want to sit down, you know, or at least do
- 5:17Speaker 2: a telemedicine that is it with somebody. I can tell
- 5:19Speaker 2: you that the company that I feel probably the most
- 5:21Speaker 2: confident in that cares, that cares about their sourcing, that
- 5:25Speaker 2: has high quality like triple tested, third party tested, would
- 5:30Speaker 2: be ways to there are ways to well, that's Brigham
- 5:33Speaker 2: Buller's you know company that he has the revive Ourx
- 5:38Speaker 2: compound pharmacy out of Austin, Texas. Okay, they They are
- 5:41Speaker 2: somebody that really focuses on purity and they have absolutely
- 5:47Speaker 2: second to non clinicians that are going to sit there
- 5:49Speaker 2: and go through your blood work and discuss what each
- 5:51Speaker 2: mechanism would do and what it would benefit.
- 5:53Speaker 1: All right, very good sounds like, do your research, folks.
- 5:56Speaker 1: Paul Fullford, healthy living expert buddy, thank you so much
- 5:59Speaker 1: for being with me. I appreciate you.
- 6:01Speaker 2: Thank you once again, JT.